Stryker Corporation (SYK) Stock Analysis
A live, multi-source view of Stryker Corporation (SYK): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications.
Sector: Healthcare · Industry: Medical Devices · United States · 56,000 employees · stryker.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Stryker Corporation (SYK) had a market capitalization of $116.27B, a trailing P/E of 31.4 (forward 18.1), a dividend yield of 1.16% and a beta of 0.77; the shares traded in a 52-week range of $281.00 – $395.90 (-22.9% over the year).
- Market cap
- $116.27B
- Enterprise value
- $128.24B
- Trailing P/E
- 31.4
- Forward P/E
- 18.1
- PEG ratio
- 1.31
- Price / book
- 4.85
- EPS (trailing)
- $9.64
- EPS (forward)
- $16.75
- Dividend yield
- 1.16%
- Payout ratio
- 36.1%
- Ex-dividend date
- 2026-09-30
- 52-week range
- $281.00 – $395.90
- 52-week change
- -22.9%
- Beta
- 0.77
- Average volume
- 2.4M
- Shares outstanding
- 383.6M
- Short % of float
- 1.89%
- Profit margin
- 14.4%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Stryker Corporation (SYK) last closed at $270.01 (the last completed close before that scan).
Technicals at the scan: RSI 23 (oversold territory), price -15.2% versus its 20-day average, 20-day versus 50-day average spread -2.3%, MACD histogram -6.59.
Sentiment inputs: 71% of recent Finnhub-scored headlines read bullish; StockTwits 100% bullish; Reddit mentions 0% over 24 hours; analyst consensus score 76/100.
Next scheduled company event: in 48 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 3 sells of SYK; corporate insiders filed 5 buys and 22 sells (6 distinct filers, latest disclosure 2026-09-02). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Ronda E. Stryker (0B/20S), Mary K. Brainerd (5B/0S), Thomas H. Kean, Jr. (0B/2S), Dylan Bram Crotty (0B/1S), Debra King (0B/1S), Alan Armstrong (0B/1S). Who is trading what
RapidTradeView pick record
SYK has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Stryker Corporation (SYK) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell SYK.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.